Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × pexidartinib × Clear all

Sponsor

Conditions

Giant Cell Tumor of Tendon Sheath 5 Synovitis, Pigmented Villonodular 3 Melanoma 2 Gastrointestinal Stromal Tumors 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Solid Tumors 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡